This review examines the evolution of intravenous (IV) iron therapies, focusing on newer formulations such as ferumoxytol, ferric carboxymaltose, and iron isomaltoside. These agents possess more stable iron-carbohydrate complexes, allowing for higher single-dose administrations with reduced labile iron release, thereby minimizing infusion-related adverse events. Their enhanced safety profiles and dosing
This review discusses the clinical experience with intravenous ferric carboxymaltose (FCM) for treating iron deficiency anemia (IDA) in adults intolerant to or unresponsive to oral iron, or with nondialysis-dependent chronic kidney disease. FCM allows administration of up to 750 mg per dose (totaling 1500 mg over two doses), delivered over
This FDA-conducted study assessed the in vitro cellular iron uptake of brand (Ferrlecit®) and generic sodium ferric gluconate (SFG) formulations using three human macrophage cell lines (THP-1, HL-60, U937). Utilizing a colorimetric assay, the researchers found no significant differences in iron uptake across all cell lines, concentrations (10, 20, 40
This randomized, multicenter, double-blind clinical trial assessed the safety and efficacy of intravenous ferumoxytol compared to ferric carboxymaltose (FCM) in patients with iron deficiency anemia (IDA) unresponsive or intolerant to oral iron. A total of 1,997 patients received either ferumoxytol (n=997) or FCM (n=1000) over ≥15 minutes on days 1
These guidelines, developed by the British Society of Gastroenterology, provide comprehensive recommendations for the diagnosis and management of iron deficiency anemia (IDA) in adults. Key points include the importance of confirming IDA with appropriate laboratory tests (e.g., serum ferritin), investigating underlying causes such as gastrointestinal bleeding, and initiating treatment with
This review provides a clinical guide for evaluating microcytosis (MCV < 80 fL), emphasizing iron deficiency anemia and thalassemia trait as the most common causes. It outlines a diagnostic approach beginning with serum ferritin, followed by additional labs like transferrin saturation and hemoglobin electrophoresis based on results. The article stresses
This AGA clinical practice guideline provides a standardized, evidence-based approach to the gastrointestinal evaluation of iron deficiency anemia (IDA) in adult men and postmenopausal women. It recommends initial diagnostic workup using bidirectional endoscopy (EGD and colonoscopy) and suggests additional testing, such as capsule endoscopy, in cases where the initial evaluation
